alzheimer's disease - Search News

News

FDA Clears 1st Blood Test to Diagnose Alzheimer’s Disease

FDA approves blood test to detect Alzheimer’s disease

The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by Fujirebio Diagnostics, is simple: Early detection of beta-amyloid plaques linked to the neurocognitive disease in adults 55 and older who are exhibiting signs and symptoms of the disorder.

Newsweek on MSN · 18h

'Important' Alzheimer's Treatment Breakthrough Gets FDA Approval

The approval comes as two Alzheimer's drugs—lecanemab and donanemab—are already authorized by the FDA. Both are antibody therapies that target amyloid plaques and are believed to be more effective when administered earlier in the disease's progression.

NPR · 13h

First FDA-cleared Alzheimer's blood test could make diagnoses faster, more accurate

The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and treat the disease.

2hon MSN

Could cold sores increase the risk of Alzheimer’s disease? A new study is no cause for panic

Alzheimer’s is a complex disease caused by many interacting factors. It’s possible the herpes virus could play a small role – ...

11hon MSN

These Women’s Mothers Had Alzheimer’s Disease—This Is What They Wish You Knew

Brain health advocates share tips for detecting Alzheimer’s Disease early, including tests and early signs. Plus, prevention ...

6don MSN

Alzheimer's disease could be prevented by antiviral drug already on market

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for ...

Now THIS simple blood test can reveal the onset of Alzheimer's

Alzheimer’s disease, which is one of the most common forms of dementia, affects millions worldwide, and early detection has ...

Common ailment linked to higher risk of Alzheimer’s disease: ‘Public health priority’

Alzheimer’s is the seventh-leading cause of death among US adults, with the average patient living four to eight years after diagnosis.

13hon MSN

Insulin resistance in brain may be one of the factors linking Alzheimer's disease and epilepsy

Researchers at the University of São Paulo (USP) in Brazil have succeeded in showing, in an animal model, that the process of ...

Discover WildScience on MSN3h

AI Uncovers a Potential Trigger for Alzheimer’s and a Promising Treatment

Artificial intelligence has played a pivotal role in uncovering a potential trigger for Alzheimer’s disease and identifying a promising treatment. Researchers at the University of California, San ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results